Next video will start in 30 seconds

Interview with iSIGN CEO Philip Sassower

Close Open

Developing Innovative Treatments for Alzheimer's

Investing - Small-Cap Market Intelligence • 10m

Up Next in Investing - Small-Cap Market Intelligence

  • Interview with iSIGN CEO Philip Sassower

    iSIGN (OTC: ISGN) is a leading provider of digital transaction management (DTM) software enabling fully digital (paperless) business processes. iSIGN’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and variou...

  • CTD Holdings (OTCQB: CTDH)

    CTD Holdings (OTCQB: CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rar...

  • SG Blocks (NASDAQ: SGBX)

    Watch our exclusive interview with SG Blocks (NASDAQ: SGBX), a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. SGBX offers a product that exceeds many standard building code requirements, and also supports de...